Commission Implementing Regulation (EU) 2021/348 of 25 February 2021 approving carbendazim as an existing active substance for use in biocidal products of product-types 7 and 10 (Text with EEA relevance)

Article 1

Carbendazim is approved as an active substance for use in biocidal products of product-types 7 and 10, subject to the specifications and conditions set out in the Annex.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

ANNEX

ANNEX
Common Name
IUPAC Name
Identification Numbers
Minimum degree of purity of the active substance  ( 1 )
Date of approval
Expiry date of approval
Product type
Specific conditions
Carbendazim
IUPAC Name: Methyl-benzimidazol-2-ylcarbamate
EC No: 234-232-0
CAS No: 10605-21-7
99,0 % w/w
1 February 2022
31 January 2025
7
Carbendazim is considered a candidate for substitution in accordance with points (a) and (d) of Article 10(1) of Regulation (EU) No 528/2012.
The authorisations of biocidal products are subject to the following conditions:
1.
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance. In addition, pursuant to point 10 of Annex VI to Regulation (EU) No 528/2012, the product assessment shall include an evaluation as to whether the conditions of Article 5(2) of Regulation (EU) No 528/2012 can be satisfied.
2.
Products shall only be authorised for use in Member States where at least one of the conditions laid down in Article 5(2) of Regulation (EU) No 528/2012 is met.
3.
Products shall not be authorised for use in paints which are intended to be used outdoors.
The placing on the market of treated articles is subject to the following conditions:
1.
Paints treated with or incorporating carbendazim shall not be placed on the market for outdoor use.
2.
The person responsible for the placing on the market of a paint treated with or incorporating carbendazim shall ensure that the label of that paint indicates that it shall not be used outdoors.
3.
The person responsible for the placing on the market of a treated article treated with or incorporating carbendazim shall ensure that the label of that treated article provides the information listed in the second subparagraph of Article 58(3) of Regulation (EU) No 528/2012.
10
Carbendazim is considered a candidate for substitution in accordance with points (a) and (d) of Article 10(1) of Regulation (EU) No 528/2012.
The authorisations of biocidal products are subject to the following conditions:
1.
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance. In addition, pursuant to point 10 of Annex VI to Regulation (EU) No 528/2012, the product assessment shall include an evaluation as to whether the conditions of Article 5(2) of Regulation (EU) No 528/2012 can be satisfied.
2.
Products shall only be authorised for use in Member States where at least one of the conditions laid down in Article 5(2) of Regulation (EU) No 528/2012 is met.
3.
Products shall not be authorised for use in plasters which are intended to be used outdoors..
The placing on the market of treated articles is subject to the following conditions:
1.
Plasters treated with or incorporating carbendazim shall not be placed on the market for outdoor use.
2.
The person responsible for the placing on the market of a plaster treated with or incorporating carbendazim shall ensure that the label of that plaster indicates that it shall not be used outdoors.
3.
The person responsible for the placing on the market of a treated article treated with or incorporating carbendazim shall ensure that the label of that treated article provides the information listed in the second subparagraph of Article 58(3) of Regulation (EU) No 528/2012.
( 1 )   The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.

Commission Implementing Regulation (EU) 2021/348 of 25 February 2021 approving carbendazim as an existing active substance for use in biocidal products of product-types 7 and 10 (Text with EEA relevance)

Schedules & Appendices

Cite this act